Common Diseases & Disorders Codexery

Gestational diabetes

High blood sugar first recognized during pregnancy.

Gestational diabetes

Gestational diabetes is a condition where high blood sugar develops during pregnancy in someone who did not previously have diabetes. It is formally defined as any degree of glucose intolerance that is first recognized during pregnancy, which means it may include cases where undiagnosed diabetes existed before conception or developed coincidentally with pregnancy. The condition often produces few noticeable symptoms. It is most common in the third trimester, affecting between 3% and 9% of pregnancies, though rates vary by population due to differing screening methods and diagnostic criteria. Prevalence is lower in those under 20 years old and higher in those over 44. Certain ethnic groups—including Asians, American Indians, Indigenous Australians, and Pacific Islanders—face elevated risk. The underlying causes involve insulin resistance or insufficient insulin production during pregnancy. Risk factors include being overweight, a prior history of gestational diabetes, a family history of type 2 diabetes, and polycystic ovarian syndrome. Diagnosis relies on blood tests, with screening recommended between 24 and 28 weeks for those at normal risk, and earlier for high-risk individuals. The White classification system, named after researcher Priscilla White, distinguishes gestational diabetes (type A) from pregestational diabetes, and further subdivides gestational diabetes into type A1, where diet alone controls glucose, and type A2, requiring medication or insulin. Other diagnostic criteria include the Carpenter-Coustan and National Diabetes Data Group thresholds, as well as the DIPSI guidelines used in India, which use a single two-hour plasma glucose value of 140 mg/dL or higher after a 75-gram glucose load. Untreated gestational diabetes raises risks for the baby, including macrosomia (excessive birth weight), neonatal hypoglycemia, jaundice, and stillbirth. Long-term, children have higher odds of overweight and type 2 diabetes. For the mother, obesity increases the likelihood of pre-eclampsia, cesarean delivery, and macrosomia. Management involves healthy eating, exercise, medication such as metformin, and sometimes insulin injections; most people control blood sugar with diet and exercise alone, and blood sugar testing four times daily is often recommended. Breastfeeding soon after birth is encouraged. In 90% of cases, the condition resolves after delivery

field
Obstetrics, Endocrinology
known_for
Condition of high blood sugar during pregnancy, associated with increased risk of complications for mother and child
prevalence
3–9% of pregnancies
age_under_20_prevalence
1%
age_over_44_prevalence
13%
resolution_rate
90% resolve after birth

Quick Facts

Field
Obstetrics and endocrinology
Symptoms
Typically few symptoms
Complications
Pre-eclampsia, stillbirth, depression, increased risk of requiring a caesarean section
Onset
Most common last three months of pregnancy
Causes
Not enough insulin in the setting of insulin resistance
Risks
Overweight, previously having gestational diabetes, family history of type 2 diabetes, polycystic ovarian syndrome
Diagnosis
Screening blood tests
Prevention
Maintaining a healthy weight and exercising before pregnancy
Treatment
Diabetic diet, exercise, insulin injections
Frequency
~6% of pregnancies

Facts from the source article.

Lore & Background

Gestational diabetes is a condition where high blood sugar develops during pregnancy in someone who did not previously have diabetes, typically producing few noticeable symptoms. It arises from insulin resistance or reduced insulin production. Diagnosis relies on blood tests; for those at normal risk, screening is recommended between 24 and 28 weeks of gestation, while high-risk individuals may be tested at the first prenatal visit. The condition is formally defined as any degree of glucose intolerance first recognized during pregnancy, regardless of whether it resolves after birth. The White classification system distinguishes gestational diabetes (type A) from pregestational diabetes, with type A1 managed by diet alone and type A2 requiring insulin or other medications. Diagnostic criteria vary: the Carpenter and Coustan guidelines use a 100-gram glucose tolerance test with fasting, one-hour, two-hour, and three-hour thresholds of 95, 180, 155, and 140 mg/dL, respectively; the National Diabetes Data Group sets higher cutoffs (105, 190, 165, and 145 mg/dL). The DIPSI guidelines, approved in India, diagnose gestational diabetes with a single two-hour plasma glucose value of 140 mg/dL or higher after a 75-gram glucose load, allowing non-fasting testing in low-resource settings. Risk factors include being overweight, prior gestational diabetes, family history of type 2 diabetes, and polycystic ovarian syndrome. Genetic factors also play a role, with polymorphisms in at least ten genes—most notably TCF7L2 and MTNR1B—linked to increased risk. Gestational diabetes affects 3–9% of pregnancies, peaking in the third trimester, and is more common in Asians, American Indians, Indigenous Australians, and Pacific Islanders. It occurs in 1% of pregnancies under age 20 and 13% over age 44. Obesity raises the rates of pre-eclampsia, cesarean sections, and fetal macrosomia. Poorly treated cases increase risks for the baby, including macrosomia (birth weight over 4,000 g), neonatal hypoglycemia, jaundice, and stillbirth. Long-term, children face higher odds of overweight and type 2 diabetes. In 90% of cases, the condition resolves after delivery, but affected individuals remain at elevated risk for developing type 2 diabetes later.

Reader's Guide

Gestational diabetes is significant because it affects a substantial proportion of pregnancies worldwide and carries both immediate and long-term health implications for mother and child. The condition highlights the interplay between pregnancy hormones and insulin resistance, with placental hormones like cortisol and progesterone contributing to reduced insulin action. The White classification system provides a framework for assessing risk and guiding management, distinguishing between diet-controlled and medication-required cases. The legacy of gestational diabetes research includes improved screening protocols, such as universal screening between 24 and 28 weeks, and preventive measures like maintaining a healthy weight and exercising before pregnancy. Long-term, children of affected pregnancies are at higher risk of obesity and type 2 diabetes, while mothers face increased risk of developing type 2 diabetes themselves. The condition's variability across populations—due to genetic factors, screening strategies, and diagnostic criteria—underscores the need for tailored approaches in different settings. The DIPSI guidelines, for example, offer a simplified test suitable for low-resource environments. Overall, gestational diabetes serves as a critical window for intervention that can reduce perinatal complications and mitigate future metabolic disease.

Did You Know?

Frequently Asked Questions

Who is Gestational diabetes?

Gestational diabetes is a pregnancy-specific condition in which a person who had no prior diabetes develops elevated blood-sugar levels, typically first detected during the third trimester. It is formally defined as any degree of glucose intolerance whose onset or initial recognition falls within a pregnancy, whether or not the individual already had undiagnosed diabetes.

What are Gestational diabetes's 'powers' or role in the story?

Its main effect is raising maternal blood glucose, which in turn increases the risk of complications for both the expecting parent and the developing baby. Notably, it usually presents with few or no outward symptoms, making routine screening the primary way it gets caught.

How widespread is Gestational diabetes in the 'universe'?

It affects roughly 3–9 % of all pregnancies, with the rate climbing sharply by age: about 1 % for those under 20 but jumping to around 13 % for those over 44. Its peak activity window is the third trimester, when hormonal shifts most strongly stress glucose regulation.

How does Gestational diabetes's story end?

In approximately 90 % of cases, the condition resolves once the baby is delivered and the placenta is expelled, returning blood-sugar levels to their pre-pregnancy baseline. The remaining cases may progress to or reveal a pre-existing type 2 diabetes, so follow-up testing is standard.

Why is Gestational diabetes important to the canon?

It sits at the intersection of obstetrics and endocrinology, serving as a key early-warning signal that a person's glucose handling may be compromised even when no diabetes was previously known. Because it can mask undiagnosed diabetes or coincide with its onset, catching it during pregnancy is considered a critical screening milestone for long-term metabolic health.

More in Common Diseases & Disorders 1-24

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →